These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 21301704)
1. No time to lose--high throughput screening to assess nanomaterial safety. Damoiseaux R; George S; Li M; Pokhrel S; Ji Z; France B; Xia T; Suarez E; Rallo R; Mädler L; Cohen Y; Hoek EM; Nel A Nanoscale; 2011 Apr; 3(4):1345-60. PubMed ID: 21301704 [TBL] [Abstract][Full Text] [Related]
2. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Nel A; Xia T; Meng H; Wang X; Lin S; Ji Z; Zhang H Acc Chem Res; 2013 Mar; 46(3):607-21. PubMed ID: 22676423 [TBL] [Abstract][Full Text] [Related]
4. Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials. Liu Q; Wang X; Xia T Anal Bioanal Chem; 2018 Sep; 410(24):6097-6111. PubMed ID: 30066194 [TBL] [Abstract][Full Text] [Related]
5. Nanomaterials in the environment: from materials to high-throughput screening to organisms. Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306 [TBL] [Abstract][Full Text] [Related]
6. In silico analysis of nanomaterials hazard and risk. Cohen Y; Rallo R; Liu R; Liu HH Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971 [TBL] [Abstract][Full Text] [Related]
7. A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment. Nel AE; Nasser E; Godwin H; Avery D; Bahadori T; Bergeson L; Beryt E; Bonner JC; Boverhof D; Carter J; Castranova V; Deshazo JR; Hussain SM; Kane AB; Klaessig F; Kuempel E; Lafranconi M; Landsiedel R; Malloy T; Miller MB; Morris J; Moss K; Oberdorster G; Pinkerton K; Pleus RC; Shatkin JA; Thomas R; Tolaymat T; Wang A; Wong J ACS Nano; 2013 Aug; 7(8):6422-33. PubMed ID: 23924032 [TBL] [Abstract][Full Text] [Related]
8. The need for novel approaches in ecotoxicity of engineered nanomaterials. Kumar A; Dhawan A; Shanker R J Biomed Nanotechnol; 2011 Feb; 7(1):79-80. PubMed ID: 21485813 [TBL] [Abstract][Full Text] [Related]
13. Toxicological aspects for nanomaterial in humans. Dusinska M; Magdolenova Z; Fjellsbø LM Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759 [TBL] [Abstract][Full Text] [Related]
14. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. George S; Xia T; Rallo R; Zhao Y; Ji Z; Lin S; Wang X; Zhang H; France B; Schoenfeld D; Damoiseaux R; Liu R; Lin S; Bradley KA; Cohen Y; Nel AE ACS Nano; 2011 Mar; 5(3):1805-17. PubMed ID: 21323332 [TBL] [Abstract][Full Text] [Related]
15. Do nanomedicines require novel safety assessments to ensure their safety for long-term human use? Hoet P; Legiest B; Geys J; Nemery B Drug Saf; 2009; 32(8):625-36. PubMed ID: 19591528 [TBL] [Abstract][Full Text] [Related]
16. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs. Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754 [TBL] [Abstract][Full Text] [Related]
17. Nanomaterial cell interactions: are current in vitro tests reliable? Hirsch C; Roesslein M; Krug HF; Wick P Nanomedicine (Lond); 2011 Jul; 6(5):837-47. PubMed ID: 21793675 [TBL] [Abstract][Full Text] [Related]
18. Stem Cells, a New Generation Model for Predictive Nano Toxicological Assessment. Suma RN; Mohanan PV Curr Drug Metab; 2015; 16(10):932-9. PubMed ID: 26467070 [TBL] [Abstract][Full Text] [Related]